Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

Rosenthal E, Poirée M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L, Myers RP, Morlat P, Pialoux G, Pol S, Cacoub P; GERMIVIC Joint Study Group.

AIDS. 2003 Aug 15;17(12):1803-9.

PMID:
12891066
2.

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).

Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, Michelet C, Pol S, Perronne C, Cacoub P; GERMIVIC Joint Study Group.

J Viral Hepat. 2007 Mar;14(3):183-8.

PMID:
17305884
3.

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortavic/Mortalité 2005 Study Group.

HIV Med. 2009 May;10(5):282-9. doi: 10.1111/j.1468-1293.2008.00686.x. Epub 2009 Feb 15.

4.

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group.

Int J Epidemiol. 2005 Feb;34(1):121-30. Epub 2004 Nov 23.

PMID:
15561752
5.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34.

PMID:
16878047
6.

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, Decoin M, Djossou F, Beylot J, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

HIV Med. 2002 Jul;3(3):195-9.

7.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, Yang SY.

HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.

8.

Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.

Martínez E, Milinkovic A, Buira E, de Lazzari E, León A, Larrousse M, Loncá M, Laguno M, Blanco JL, Mallolas J, García F, Miró JM, Gatell JM.

HIV Med. 2007 May;8(4):251-8.

9.

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59.

PMID:
18223361
10.

Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans.

El-Serag HB, Giordano TP, Kramer J, Richardson P, Souchek J.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):175-83.

PMID:
15704052
11.

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.

Merchante N, Girón-González JA, González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martínez-Sierra C, Macías J, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

AIDS. 2006 Jan 2;20(1):49-57.

PMID:
16327319
12.

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.

Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N.

Clin Infect Dis. 2006 May 15;42(10):1481-7. Epub 2006 Apr 12.

PMID:
16619163
14.

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.

PMID:
16394852
15.

Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.

Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.

Haemophilia. 2005 Jul;11(4):360-5.

PMID:
16011588
16.

Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.

Quintana M, del Amo J, Barrasa A, Pérez-Hoyos S, Ferreros I, Hernández F, Villar A, Jiménez V, Bolúmar F.

Haemophilia. 2003 Sep;9(5):605-12.

PMID:
14511302
17.

Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.

Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, Antona D, Bovet M, Mechain M, Asselah T, Desenclos JC, Jougla E.

J Hepatol. 2008 Feb;48(2):200-7. Epub 2007 Nov 20.

PMID:
18086507
18.

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P.

Cancer. 2004 Jul 15;101(2):317-24.

19.

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.

Vallet-Pichard A, Pol S.

J Hepatol. 2006;44(1 Suppl):S28-34. Epub 2005 Nov 21. Review.

PMID:
16343684
20.

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G; Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases (GERMVIC Study Group).

Clin Infect Dis. 2001 Apr 15;32(8):1207-14. Epub 2001 Mar 28.

PMID:
11283811

Supplemental Content

Support Center